Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000904454-14-000619
Filing Date
2014-09-04
Accepted
2014-09-04 19:23:46
Documents
1
Period of Report
2014-09-02

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 4  
1 PRIMARY DOCUMENT edgar.xml 4 7383
  Complete submission text file 0000904454-14-000619.txt   8859
Mailing Address 100 ACORN PARK DRIVE CAMBRIDGE MA 02140
Business Address 100 ACORN PARK DRIVE CAMBRIDGE MA 02140 617-876-8191
GENOCEA BIOSCIENCES, INC. (Issuer) CIK: 0001457612 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address CAMBRIDGE DISCOVERY PARK 100 ACORN PARK DRIVE, 5TH FLOOR CAMBRIDGE MA 02140
Business Address
Giannasca Paul (Reporting) CIK: 0001591874 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36289 | Film No.: 141084288